The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Phase 3b/4 study
-
Could a Phase 3b/4 study be considered under the RWE guidance? or under the Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising?
Hello @tk2022
The feature of being phase 3b/4 does not in and of itself disqualify a study from either RWE or study duration.
